Insight Wealth Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$336K Buy
290
+17
+6% +$20.1K 0.03% 153
2026
Q2
$325K Buy
273
+15
+6% +$15.3K 0.03% 151
2026
Q1
$237K Buy
258
+16
+7% +$16.2K 0.03% 165
2025
Q4
$260K Buy
+242
New +$231K 0.03% 157
2024
Q3
– Sell
-222
Closed -$201K – 168
2024
Q2
$201K Buy
+222
New +$178K 0.03% 155
2019
Q2
– Sell
-13,371
Closed -$1.74M – 164
2019
Q1
$1.74M Buy
13,371
+453
+4% +$55.1K 0.48% 40
2018
Q4
$1.5M Buy
+12,918
New +$1.44M 0.46% 34

Other funds holding LLY

Insight Wealth Strategies's LLY Position: Q3 2026 in Review

Insight Wealth Strategies increased its Eli Lilly (LLY) stake by 6.2% in Q3 2026, buying an estimated $20.1K and bringing the position to 290 shares worth $336K. The position accounts for 0.03% of the portfolio, ranked #153.

Insight Wealth Strategies first reported a position in LLY in Q4 2018 and has held it in 7 quarters since. The position peaked at $1.74M in Q1 2019. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Insight Wealth Strategies held 290 shares of Eli Lilly worth $336K as of Q3 2026.
  • Insight Wealth Strategies bought 17 Eli Lilly shares in Q3 2026, an estimated $20.1K.
  • Eli Lilly made up 0.03% of Insight Wealth Strategies's portfolio in Q3 2026, its #153 holding.
  • Insight Wealth Strategies first reported a position in Eli Lilly in Q4 2018 and has held it in 7 quarters since.
  • Insight Wealth Strategies's Eli Lilly position peaked at $1.74M in Q1 2019.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Insight Wealth Strategies's 13F filing for Q3 2026, filed 9 Oct 2026.